Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r therapy by paired comparison analysis for each patient. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in patients before and after DCV/ASV therapy. by Miyabi Miura (18605126)

Subjects:

Consolidated standard of reporting trials (CONSORT) diagram. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases for DCV/ASV treatment. by Miyabi Miura (18605126)

Subjects:

Patient characteristics for OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in SVR and non-SVR cases. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in the SVR cases before and after OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Graphical representation of before OBV/PTV/r treatment by Gene Ontology (GO) enrichment of differentially expressed genes between the SVR and non-SVR groups and analysis of the can... by Miyabi Miura (18605126)

Subjects:

Raw data of frequencies of peripheral blood immune cells with each profile for OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Frequencies of peripheral blood immune cells with each profile in all patients before and after OBV/PTV/r treatment. by Miyabi Miura (18605126)

Subjects:

Peripheral blood immune cell profiles. by Miyabi Miura (18605126)

Subjects:

Significantly changed USS in the <i>sf3b1</i> mutants. by Bei Zhang (428038)

Significantly changed AS events in the <i>sf3b1</i> mutants. by Bei Zhang (428038)

After moderate and severe TBI, PWI revealed CBF was significantly decreased in the ipsilateral cortex and hippocampus at several time points relative to sham animals. by Juliana Sanchez-Molano (16792787)

Structural path significance in bootstrapping. by Ayalew Ali (18554538)

Subjects:

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. by Lijuan Liu (136685)

Subjects:

Schematic representation of the study protocol. by Neng Pan (5262032)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

Subjects:

Comparison within groups. by Neng Pan (5262032)

Subjects:

Comparison before and after the experiment in each group. by Neng Pan (5262032)

Subjects: